Search Book Here:

Pharmaceutical Dosage Forms: Parenteral Medication (Volume 3)

University of Tennessee, Memphis. Third and final volume of the second edition of an in-depth text on parenteral medications, for graduate and undergraduate students, and industrial or hospital pharmacists. 17 U.S. contributors. DNLM: Infusions, Parenteral.

Public Relations for Pharmacists

Equips pharmacy professionals with the tools necessary to advance their practice through public relations. The first book designed specifically for pharmacists, it explains how to work with the media; how to write news releases, public service announcements, and op-ed pieces; how to prepare for media interviews; how to work with PR agencies; and how to become involved in the community. The book contains lists of public relations do's and don'ts, points to consider, and tips for succeeding. Examples of successful PR activities and campaign and sample news release, public service announcement, op-ed article, and media pitch letter are also included.

Healthcare Management Dictionary

A comprehensive reference book to help understand clinical and management terms, acronyms and jargon commonly used within the NHS. It includes terms used throughout Primary, Secondary and Social Health Care, and general management terms used throughout the public and private sectors. Website links are provided for further information. This book is aimed at all healthcare professionals and everyone is contact with the NHS and health industry, including academics, pharmaceutical company staff, social services managers and journalists.

Dictionary for Clinical Trials

As a result of the expansion in the area of pharmaceutical medicine there is an ever-increasing need for educational resources. The Dictionary of Clinical Trials, Second Edition comprehensively explains the 3000 words and short phrases commonly used when designing, running, analysing and reporting clinical trials.

This book is a quick, pocket reference tool to understand the common and less well-used terms within the discipline of clinical trials, and provides an alternative to the textbooks available. Terms are heavily cross-referenced, which helps the reader to understand how terms fit into the broad picture of clinical trials.

Wide ranging, brief, pragmatic explanations of clinical trial terminology
Scope includes medical, statistical, epidemiological, ethical, regulatory and data management terminology
Thoroughly revised and expanded - increase of 280 terms from First Edition, reference to Cochrane included
From the reviews of the First Edition:

"This invaluable text explains the majority of clinical trial terms, in alphabetical order, that are likely to be found in clinical trial protocols, reports, regulatory guidelines, and published manuscripts... Fully comprehensive - provides definitions of clinical trial terms in one complete volume... Includes extensive use of graphs throughout." LA DOC STI

"...covers a range of subject matter, with emphasis on medical, statistical, epidemiological and ethical terms... a useful adjunct to standard clinical trial texts... a reference source to keep within easy reach." TALANTA

The Dictionary of Clinical Trials, Second Edition is a ‘must-have’ for all pharmaceutical companies who conduct a lot of clinical trials, in all or one therapeutic area. The book is also of interest for public health and health science workers, and for contract research organisations and departments of medicine, where medics are involved with clinical trials.

Handbook of Pharmaceutical Manufacturing Formulations: Liquid Products (Volume 3 of 6)

The third volume in the six-volume Handbook of Pharmaceutical Manufacturing Formulations, this book covers liquid drugs, which include formulations of non-sterile drugs administered by any route in the form of solutions (monomeric and multimeric), suspensions (powder and liquid), drops, extracts, elixirs, tinctures, paints, sprays, colloidons, emulsions, aerosols, and other fluid preparations from publicly available but widely dispersed information from FDA New Drug Applications (NDA), patent applications, and other sources of generic and proprietary formulations. Each entry begins with a fully validated scaleable manufacturing formula and a summary of manufacturing process. The book provides a detailed discussion on the difficulties encountered in formulating and manufacturing liquid drugs, the common elements of formulation. The section on regulatory and manufacturing guidance deals with the topics of changes to approved NDAs and aNDAs, post-approval changes to semisolid drugs, global manufacturing practices and guidelines, compliance program guidance manual for FDA staff covering drug manufacturing inspections program, waiver of in vivo bioavailability studies for immediate release solid drugs based on a biopharmaceutics classification, in addition to providing quick tips on resolving the common problems in formulating uncompressed drugs.

GMP/ISO Quality Audit Manual for Healthcare Manufacturers and Their Suppliers, Sixth Edition, (Volume 2 - Regulations, Standards, and Guidelines)

Volume 2 of this set contains the full text of the FDA regulations, EC and IPEC guidelines, and ISO/BSI standards referenced in the checklists furnished in Volume I. The book is presented in an convenient, easy-to-read format, organized to provide fast access to the guidelines and regulations of interest.

GMP/ISO Quality Audit Manual for Healthcare Manufacturers and their Suppliers, Sixth Edition, (Volume 1 - With Checklis)

Volume 1 of this three-part package provides a complete set of checklists for internal and contract device and drug manufacturers and developers, contract software developers, and suppliers of chemical, printed material, electronic component, and general supplies. It also includes a simulated QSIT audit, and a new-product market launch. All of these are referenced to the relevant relevant FDA regulations, EC and IPEC guidelines, and ISO/BSI standards. The text also explains various audit types, do's and don'ts for auditors, and guidance for audit preparation, performance, conclusion, report derivation, and follow up activities. A CD-ROM packaged with the book contains all of the checklists in a customizable electronic format.

The Japanese Pharmacopoeia Fifteenth Edition (JP XV)

This is the English version of the 15th edition of the "Japanese Pharmacopoeia". It provides the official Japanese standard for the description and quality of drug substances and products. It contains over 1,300 articles regarding: general rules for preparations; processes and apparatus; monographs on drugs; and infrared reference spectra and ultraviolet-visible reference spectra.

Official Monographs provides 1483 articles, including 102 articles newly added and 8 articles deleted. Comprises the following items in order: The Ministry of Health, Labour and Welfare Ministerial Notification; Contents; Preface; General Notices; General Rules for Crude Drugs; General Rules for Preparations; General Tests, Processes and Apparatus; Official Monographs, including Monographs for Crude Drugs; Infrared Reference Spectra; Ultraviolet-visual Reference Spectra; General Information; Atomic Weight Table (2004) and Standard Atomic Weights 2004 as Appendix ; and Cumulative Index (English, Latin and Japanese titles).

Litt's Drug Eruption Reference Manual Including Drug Interactions, 14th Edition

Litt's Drug Eruption Reference Manual, 14th edition, has been updated and improved and incorporates dermatological drug eruptions plus reactions affecting the nails, hair, nails, eyes and mucosal.. This valuable resource also includes herbal and supplements reactions, in addition to hazardous drug-drug interactions. This book is a must have for all dermatologists, general practitioners and those working in emergency medicine.

Nanotherapeutics: Drug Delivery Concepts in Nanoscience

An important and exciting aspect in the newly developing field of nanomedicine is the use of nanoparticle drug delivery systems allowing for innovative therapeutic approaches. Due to their small size, these drug delivery systems are promising tools in therapeutic approaches such as selective or targeted drug delivery towards a specific tissue or organ, enhanced drug transport across biological barriers, and intracellular drug delivery.

This timely book provides an overview of possible therapeutic applications. The first part of the book highlights general properties of and phenomena observed with nanoparticles, and the subsequent consequences for applications in drug delivery. The second part focuses on the therapeutic approaches that are possible through the use of nanoparticles, with each chapter discussing a specific disease (e.g. diabetes, cancer, inflammation, etc.) and the relevant therapeutic approaches based on the design of nanoparticulate drug delivery systems. Written in a concise manner, readers will gain an insight into the basics of nanoparticle preparation as well as a more detailed account of what is therapeutically feasible by using nanoparticle approaches.

Contents: General Aspects of Nanotherapeutics: Nanocarriers in Drug Delivery - Design, Manufacture and Physicochemical Properties (C Schmidt & A Lamprecht); Transport Across Biological Barriers (N Nafee et al.); Targeting Approaches (S Cammas-Marion); Disease-Related Approaches by Nanotherapeutics: Nanoscale Cancer Therapeutics (Y Pellequer & A Lamprecht); Nanotherapeutics for Skin Diseases (N Atrux-Tallau et al.); Nanoparticles for Oral Vaccination (J M Irache et al.); Nanoparticles: Therapeutic Approaches for Bacterial Diseases (B Moulari); Nanoparticle Therapy in Parasites Diseases: Possibility and Reality! (M Larabi); Nanocarriers in the Therapy of Inflammatory Disease (A Lamprecht).

Davis's Pocket Clinical Drug Reference

Make sure your students rely on a trusted reference! This handy pocket guide shows them how to safely administer medications to their adult, pediatric, and geriatric patients, as well as pregnant and lactating women, and those with renal impairments.

Every detail is designed to make it easy for your students to find the information they need in a snap. And, they can count on it for accuracy because it s drawn from Davis s Drug Guide database.


*4 x 7 size fits in a scrub pocket.
*Nearly 1,000 abbreviated drug monographs, organized alphabetically by generic name, deliver must-know information, including...
Trade name
Drug class
Pregnancy categories
Adverse drug reactions and side effects
Dosing information for adult, pediatric, and geriatric patients, pregnant and lactating women, and renal impairment
Generic availability
Monitoring information

*Very important or life-threatening information, such as FDA black box warnings or adverse drug reactions, appears in red type.
*A colored thumb tab makes it easy for your students to find information quickly.
*The appendices features Cytochrome P450 enzyme table, Pediatric IV, immunization guidelines, and more.
*Abbreviations key appears in the front of the book and at the bottom of each page.*
Notes section covers patient safety information.
*Index provides generic and trade drug names.

Physicochemical Principles of Pharmacy, 4th Edition

Physical chemistry is the basis of rational pharmaceutical formulation and processing, and is fundamental to understanding the complexities of drug delivery and drug absorption. This textbook presents the physiochemical principles useful to the modern pharmaceutical scientist and pharmacist.

Pharmacy Case Studies

Whilst most pharmacy undergraduate texts are subject specific, "Pharmacy Case Studies" encourages students to take an integral approach to pharmacy via a series of pharmacy cases. Knowledge gained within the individual areas of law and ethics, pharmaceutics, pharmacology and pathology are tested by each example, bringing together all areas taught on the degree course. Each chapter contains five case studies, starting with uncomplicated cases and increasing in complexity as they expand.

British National Formulary 57: March 2009

This is the authoritative guide to prescribing, dispensing and administering medicines for all health care professionals. Nobody working in health care can afford to be without the latest edition of "BNF". Compiled with the advice of clinical experts and continually updated to reflect the latest evidence from all credible sources worldwide, this essential reference provides up-to-date guidance on prescribing, dispensing, administering, and monitoring medicines. Not only does the "BNF" include the widely accepted framework for the drug management of common diseases, it also includes details of medicines prescribed in the UK, with special reference to their uses, cautions, contraindications, side-effects, dosage and relative costs. This allows treatment to be tailored to the individual needs of each patient. Updated in print every six months by an expert team of pharmacists, with guidance and validation from a network of leading clinicians, and oversight by a Joint Formulary Committee with representatives from all spheres of clinical practice. "The BNF" reflects current best practice as well as legal and professional guidelines relating to the use of medicines. As a result it is used widely as a touchstone reference, and cited in Parliaments and courts as a source of authority.

The Veterinary Pharmacopoeia, Materia Medica, and Therapeutics

The Veterinary Pharmacopoeia, Materia Medica, and Therapeutics,
By George Gresswell

Clinical Pharmacology & Therapeutics Journal ~ Volume 85, Issue 5, May 2009

This issue discusses drug delivery and how advances in the pharmaceutical sciences and other scientific fields have enabled substantial progress in this field. Targeting the best route or providing a variety of routes of drug administration presents an array of benefits, such as enhanced drug administration and bioavailability, improved patient acceptance and compliance, decreased toxicity, and precise therapeutic targeting. Technologies enabling drug delivery are now commonly used to create and extend markets, and the pharmaceutical industry is turning to drug delivery to extend the revenueearning lifetime of their biggest products. Growth opportunities for drug delivery systems extend into all therapeutic classes of pharmaceuticals and encompass a wide range of compounds and formulations, presenting many options in the world market. The discovery of better delivery systems in conjunction with the discovery of novel pharmacological compounds will advance disease diagnosis and treatment.

In This Issue

Top of pageRegulating combination products

The US Food and Drug Administration (FDA) guidance on medical devices ensures the safety, efficacy, and security of drugs released to the public. The introduction of combination products has convoluted the approach historically used by the FDA to regulate single-entity products. Lauritsen details the complications faced by the agency in regulating combination products and the most important issues that must be addressed. See page 468

Top of pageAppraising the safety and efficacy of drug-eluting stents

The use of drug-eluting stents (DESs) in procedures has significantly increased worldwide since their approval by the US Food and Drug Administration in 2003. Although DESs are considered superior to bare-metal stents, safety concerns remain in the wake of reports of late stent thrombosis and myocardial infarction. In response to these concerns, new-generation DESs have been approved and made available for use. Using published clinical data, Maluenda et al. appraise the safety and efficacy of several DESs. See page 474

Top of pageEffect of multiple alleles on efavirenz disposition

Efavirenz (EVF), a non-nucleoside reverse transcriptase inhibitor used for treatment of HIV-1 infection, is primarily metabolized by CYP2B6. Although CYP3A4/3A5 has also been associated with higher EVF exposure, the influence of CYP2A6 polymorphism on EVF pharmacokinetics has not yet been determined. Arab-Alameddine et al. discuss the impact of multiple alleles on EVF disposition. See page 485

Top of pageThe growing role of nanoparticles in brain tumor diagnosis and therapy

Nanoparticle-based contrast agents designed for use in diagnosing brain tumors using magnetic resonance imaging (MRI) are capable of providing better information on the extent of tumor. The potential to visualize portions of tumors usually not detectable with conventional MRI makes nanoparticles of interest for advancing the diagnosis, operative management, and adjuvant therapy of brain tumors. Orringer et al. discuss the application of nanoparticles to brain tumor diagnosis and therapy and the many reasons that nanoparticles offer the next frontier in the treatment of brain tumors. See page 531

Top of pageBiologics in cardiovascular regenerative medicine

Stem cell–based cardiovascular regenerative medicine plays an integral role in therapy aimed at achieving structural and functional repair of the myocardium. Although experience gained in the clinical setting has shown stem cell–based cardiovascular regenerative medicine to be feasible and safe, the structural and functional benefits of such therapy have not yet reached their full potential. The very low rate of cell retention by the recipient myocardial tissue justifies review of the accumulated data to guide future developments aimed at overcoming this limitation and achieving a better outcome of stem cell delivery. See page 548

Nanotechnology in Drug Delivery

The reader will be introduced to various aspects of the fundamentals of nanotechnology based drug delivery systems and the application of these systems for the delivery of small molecules, proteins, peptides, oligonucleotides and genes. How these systems overcome challenges offered by biological barriers to drug absorption and drug targeting will also be described.

Paediatric Drug Handling (ULLA Postgraduate Pharmacy Series)

This volume in the "ULLA Series" is an introductory textbook on paediatric drug handling. Written for new pharmaceutical scientists, this book aims to give a background of paediatric pharmacy. Its scope is to give a comprehensive introduction to children's medication in terms of dosing in practice and paediatric pharmaceutics, physiological and drug disposition differences, clinical pharmacology and pharmacogenomics. Paediatric regulations around the world as well as drug licensing and clinical trials, compliance, safety and pharmacovigilance issues will also be developed.

Diabetes Mellitus: Methods and Protocols

Leading researchers and clinical investigators describe their best cutting-edge techniques for studying, at both the molecular and biochemical levels, the defects in insulin production and action associated with diabetes. Written in step-by-step detail to ensure ready reproducibility and robust results, these techniques allow investigators, both novices and those already active in the field, to study every major facet of insulin production and action. Each protocol includes an introduction to the technique, an explanation of its application, and a list of materials. Practical notes discuss how to avoid pitfalls, as well as how to adapt the methods to your own research.